دورية أكاديمية
Post-vaccination survey for monitoring the side effects associated with COVID-19 vaccines among healthcare professionals of Jazan province, Saudi Arabia.
| العنوان: | Post-vaccination survey for monitoring the side effects associated with COVID-19 vaccines among healthcare professionals of Jazan province, Saudi Arabia. |
|---|---|
| المؤلفون: | Ahsan W; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Syed NK; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Alsraeya AA; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Alhazmi HA; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Najmi A; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Bratty MA; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Javed S; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Makeen HA; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Meraya AM; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Albarraq AA; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia., Alqahtani SS; From the Department of Pharmaceutical Chemistry (Ahsan, Alhazmi, Najmi, Al Bratty); from the Department of Pharmaceutics (Javed), College of Pharmacy; from the Pharmacy Practice Research Unit (Syed, Makeen, Meraya, Albarraq, Alqahtani), Department of Clinical Pharmacy; from the College of Pharmacy (Alsraeya); and from the Substance Abuse and Toxicology Research Centre (Alhazmi), Jazan University, Jazan, Kingdom of Saudi Arabia. |
| المصدر: | Saudi medical journal [Saudi Med J] 2021 Dec; Vol. 42 (12), pp. 1341-1352. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medical Services Department, Saudi Arabian Armed Forces, Ministry Of Defence And Aviation Country of Publication: Saudi Arabia NLM ID: 7909441 Publication Model: Print Cited Medium: Internet ISSN: 0379-5284 (Print) Linking ISSN: 03795284 NLM ISO Abbreviation: Saudi Med J Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Riyadh : Medical Services Department, Saudi Arabian Armed Forces, Ministry Of Defence And Aviation Original Publication: Riyadh, Saudi Arabia, Riyadh Al-Kharj Hospital Programme. |
| مواضيع طبية MeSH: | COVID-19* , COVID-19 Vaccines*, Cross-Sectional Studies ; Delivery of Health Care ; Female ; Humans ; Male ; SARS-CoV-2 ; Saudi Arabia/epidemiology ; Vaccination |
| مستخلص: | Objectives: To identify the self-reported vaccine-related side effects among healthcare professionals (HCPs) in the Jazan province, Saudi Arabia, and determine the associated socio-demographic factors. With the recent second and third waves of coronavirus disease -19 (COVID-19) infections worldwide, the race is not only to encourage but also to achieve mass vaccination. Methods: A total of 397 HCPs from across Jazan province participated in an anonymous online cross-sectional survey conducted for a period of 45 days (March 30, 2021 to May 13, 2021) in Jazan province, Saudi Arabia. Data was collected using a validated 22-items self-report survey. Results: For both COVID-19 vaccines, majority of reports were related to flu-like symptoms including fever, chills, headache, fatigue, tiredness, and myalgia. Statistically significant associations were observed between the severity of side effects and gender (χ 2 =73.32; p <0.001), type of vaccine (χ 2 =112.08; p <0.001), and presence of known allergies (χ 2 =99.69; p <0.001). Female HCPs were more likely to report any side effects compared with male HCPs (adjusted odds ratio [AOR]: 3.72; p <0.001). Furthermore, HCPs with known allergies were more likely to report any side effects than their counterparts with unknown allergies (AOR: 16.29; p <0.001). Conclusion: The findings of the present study would help in designing educational programs aimed at combating the misconstrued fear of vaccination and highlighting the urgent need of getting vaccinated. This study also helps in the identification of factors affecting the presence and severity of side effects. (Copyright: © Saudi Medical Journal.) |
| References: | PLoS One. 2020 Sep 10;15(9):e0238458. (PMID: 32911507) J Multidiscip Healthc. 2021 Jan 12;14:45-57. (PMID: 33469298) Int J Environ Res Public Health. 2021 Sep 03;18(17):. (PMID: 34501893) Lancet. 2020 Nov 7;396(10261):1525-1534. (PMID: 32979936) J Psychiatr Res. 2020 Dec;131:177-179. (PMID: 32979693) Front Public Health. 2020 Aug 18;8:482. (PMID: 33014977) Zhongguo Dang Dai Er Ke Za Zhi. 2021 Mar;23(3):221-228. (PMID: 33691913) J Psychiatr Res. 2020 Nov;130:289-291. (PMID: 32866677) J Taibah Univ Med Sci. 2020 Aug;15(4):255-257. (PMID: 32837506) J Autoimmun. 2021 Jul;121:102663. (PMID: 34020254) Vaccines (Basel). 2021 Apr 01;9(4):. (PMID: 33915890) BMJ. 2021 Apr 14;373:n958. (PMID: 33853865) BMJ. 2021 Mar 11;372:n699. (PMID: 33707182) Cell Death Differ. 2021 Feb;28(2):626-639. (PMID: 33479399) Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91. (PMID: 11124735) Res Social Adm Pharm. 2019 Feb;15(2):214-221. (PMID: 29606610) |
| فهرسة مساهمة: | Keywords: AstraZeneca; COVID-19 vaccinations; Pfizer-BioNTech; Saudi Arabia; covishield; side effects |
| المشرفين على المادة: | 0 (COVID-19 Vaccines) |
| تواريخ الأحداث: | Date Created: 20211202 Date Completed: 20211203 Latest Revision: 20220716 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC9149761 |
| DOI: | 10.15537/smj.2021.42.12.20210576 |
| PMID: | 34853140 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 0379-5284 |
|---|---|
| DOI: | 10.15537/smj.2021.42.12.20210576 |